5.78
1.94%
0.11
Voyager Therapeutics Inc Stock (VYGR) Latest News
Great Point Partners LLC Sells 641,574 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Empowered Funds LLC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics Inc earnings beat by $0.29, revenue topped estimates - Investing.com Nigeria
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $17.00 Consensus Target Price from Analysts - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Voyager Therapeutics to advance tau silencing gene therapy for Alzheimer’s disease - BioWorld Online
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease - GlobeNewswire
Voyager's New Alzheimer's Gene Therapy Shows 73% Tau Reduction in Key Study | VYGR Stock News - StockTitan
Voyager Therapeutics’ TRACER Platform Targets CNS Market: Here’s Why I’m Neutral (VYGR) - Seeking Alpha
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Buy at StockNews.com - MarketBeat
FY2024 Earnings Forecast for VYGR Issued By HC Wainwright - MarketBeat
Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at Canaccord Genuity Group - Defense World
Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at HC Wainwright - Defense World
When the Price of (VYGR) Talks, People Listen - Stock Traders Daily
Voyager Therapeutics stock hits 52-week low at $5.71 - Investing.com India
EcoR1 Capital, LLC Increases Stake in Voyager Therapeutics Inc - GuruFocus.com
FY2024 Earnings Forecast for VYGR Issued By Leerink Partnrs - MarketBeat
Voyager Therapeutics' (VYGR) Buy Rating Reaffirmed at Canaccord Genuity Group - MarketBeat
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - MarketBeat
Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)? - Yahoo Finance
Earnings call: Voyager Therapeutics focuses on neurological therapies By Investing.com - Investing.com Canada
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q3 2024 Earnings Call Transcript - Insider Monkey
Voyager Therapeutics: Q3 Earnings Snapshot - Darien Times
Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
Voyager Therapeutics Reports Strong Q3 2024 Progress - TipRanks
Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings: Revenue Soars to $24.63M, EPS Loss of $0.16 Beats Estimates - GuruFocus.com
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Voyager Reports Third Quarter 2024 Financial and Operating Results - GlobeNewswire
Voyager Therapeutics Revenue Soars 435% in Q3, Secures $15M Novartis Deal | VYGR Stock News - StockTitan
Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada
Voyager Therapeutics (NASDAQ:VYGR) Cut to Hold at StockNews.com - MarketBeat
Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Tuesday - MarketBeat
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - The Manila Times
Voyager Therapeutics to Present at 4 Major Healthcare Investor Conferences in November | VYGR Stock News - StockTitan
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - GlobeNewswire
VYGRVoyager Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Voyager Therapeutics (VYGR) to Report Q3 2024 Earnings on November 12 | VYGR Stock News - StockTitan
Learn to Evaluate (VYGR) using the Charts - Stock Traders Daily
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? - MSN
Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance
Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.43 - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Analysts - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Lowered by StockNews.com - Defense World
StockNews.com Lowers Voyager Therapeutics (NASDAQ:VYGR) to Hold - MarketBeat
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):